Baird Financial Group, Inc. - FOAMIX PHARMACEUTICALS LTD ownership

FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 69 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of FOAMIX PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2017$188,000
-49.7%
37,988
-35.6%
0.00%
-33.3%
Q2 2016$374,000
-31.9%
58,964
-29.9%
0.00%
-40.0%
Q1 2016$549,000
-19.5%
84,1340.0%0.01%
-28.6%
Q4 2015$682,000
+520.0%
84,134
+460.9%
0.01%
+600.0%
Q3 2015$110,000
-28.6%
15,0000.0%0.00%
-50.0%
Q2 2015$154,00015,0000.00%
Other shareholders

There were no reported owners of FOAMIX PHARMACEUTICALS LTD in Q1 2017.

NameSharesValueWeighting ↓
View complete list of FOAMIX PHARMACEUTICALS LTD shareholders